Coming Soon: Conexiant’s news site is becoming MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more.
Infectious Disease
Partner With Us
Advertisement
Conexiant chevron_right Infectious Disease chevron_right Frailty in HIV linked to inflammation bone health Tcell exhaustion
From the Journals

Frailty in HIV linked to inflammation, bone health, T-cell exhaustion

Osteoprotegerin was the soluble marker most strongly linked to T-cell phenotypes among participants with frailty.

MDSpire News

Clinical Scorecard: Frailty in HIV linked to inflammation, bone health, T-cell exhaustion

At a Glance

CategoryDetail
ConditionFrailty in HIV
Key MechanismsInflammatory proteins, bone health markers, T-cell exhaustion
Target PopulationIndividuals with HIV
Care SettingHIV Infection, Aging, and Immune Function Long-Term Observational Study (HAILO)

Key Highlights

  • Frailty defined using modified Fried criteria.
  • 19 of 75 plasma markers significantly associated with frailty.
  • Lower naïve CD4 and CD8 T cells in frail individuals.
  • Osteoprotegerin (OPG) linked to T-cell phenotypes and bone health.
  • Study does not establish causation due to cross-sectional design.

Guideline-Based Recommendations

Diagnosis

  • Frailty assessed using modified Fried criteria.

Management

  • Monitor inflammatory markers and T-cell phenotypes.

Monitoring & Follow-up

  • Evaluate bone health and immune function in individuals with HIV.

Risks

  • Potential for increased frailty linked to inflammation and immune activation.

Patient & Prescribing Data

120 participants with HIV, half meeting frailty criteria.

OPG may inhibit osteoclast formation and prevent bone resorption.

Clinical Best Practices

  • Assess frailty in HIV patients using established criteria.
  • Consider inflammatory and bone health markers in management.

Related Resources & Content

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.